Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements.
about
A review on segmentation of positron emission tomography imagesState-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PETPersisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cureRepeatability of 18F-FLT PET in a Multicenter Study of Patients with High-Grade Glioma.Introduction to the analysis of PET data in oncology.Development of a nomogram combining clinical staging with (18)F-FDG PET/CT image features in non-small-cell lung cancer stage I-IIIEvaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer.Quantitative imaging biomarkers: a review of statistical methods for computer algorithm comparisons.Metabolically active tumour volume segmentation from dynamic [(18)F]FLT PET studies in non-small cell lung cancer.Measurement of metabolic tumor volume: static versus dynamic FDG scansOptimising delineation accuracy of tumours in PET for radiotherapy planning using blind deconvolution.Baseline ¹⁸F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancerNoise considerations for PET quantification using maximum and peak standardized uptake value.A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET ImagesReproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MRComputerized PET/CT image analysis in the evaluation of tumour response to therapy.Impact of partial-volume effect correction on the predictive and prognostic value of baseline 18F-FDG PET images in esophageal cancer.Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineationRepeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.Comparison of PET metabolic indices for the early assessment of tumour response in metastatic colorectal cancer patients treated by polychemotherapy.Early prediction of pathological response in locally advanced rectal cancer based on sequential 18F-FDG PET.Positron emission tomography/computerized tomography for tumor response assessment-a review of clinical practices and radiomics studiesEarly reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone.A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment.Challenges and opportunities in patient-specific, motion-managed and PET/CT-guided radiation therapy of lung cancer: review and perspective.Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.A framework based on Hidden Markov Trees for multimodal PET/CT image co-segmentation.Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.Repeatability of SUV in Oncologic 18F-FDG PET.SPEQTACLE: An automated generalized fuzzy C-means algorithm for tumor delineation in PET.The age of reason for FDG PET image-derived indices.Adaptive threshold segmentation of pituitary adenomas from FDG PET images for radiosurgery.Deformable versus rigid registration of PET/CT images for radiation treatment planning of head and neck and lung cancer patients: a retrospective dosimetric comparison.Reliability of PET/CT Shape and Heterogeneity Features in Functional and Morphologic Components of Non-Small Cell Lung Cancer Tumors: A Repeatability Analysis in a Prospective Multicenter Cohort.Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET.Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation.Semiautomatic methods for segmentation of the proliferative tumour volume on sequential FLT PET/CT images in head and neck carcinomas and their relation to clinical outcome.Robustness of intratumour ¹⁸F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma.Standardized added metabolic activity (SAM): a partial volume independent marker of total lesion glycolysis in liver metastases.
P2860
Q26825470-82B0A815-EB9B-48E5-827E-95143A78242AQ27694674-5E109EC0-5B5D-4F1D-B37C-DAE8915A04B4Q28391110-3D3B3983-1500-4613-B931-7E3859ABC212Q30275817-4BCABAF4-09F1-49E2-9924-8641B2D4371CQ30594766-8FE51350-CFFB-492D-9182-1C4447AB1CE7Q33617538-F88FED16-0CAD-4301-A54F-FBEADD7856C5Q33750115-4D756A3F-A08F-47B9-87F7-7DE8C173533DQ34681714-01E92B39-099B-4A57-92C7-991729AD7DF7Q35537570-6FBFA1AD-EAE3-4F5C-B642-58149B2DF4E9Q35774813-FA452AC5-0F83-4E1B-91C2-D2D81942E56BQ35849051-2ADB30A9-C6DA-47DB-AE69-4F740746A89EQ36032993-80BD9E4E-C510-4710-934B-0DE0F503FB19Q36158583-EC8CDB4C-8ED2-4EE4-A573-7F8DBC31A120Q36162513-CCE9E918-BB63-43AA-ABA9-0E9466060024Q36295389-EB22A057-3381-42EC-9BC4-C605623AF81CQ36295403-0717A9D6-15C2-4BAD-9CDB-76EDE91E7B55Q36335078-3D9B3D77-52F9-49AC-8ADF-9B2FF294771DQ36350466-A915B556-49C7-4811-9D0A-FDD5A2C8EC2DQ36425061-198AB560-B318-494C-A4CD-90024FD73199Q36508524-8598E587-59A4-4BB0-A023-06580A9F285CQ36918459-15EB0DAB-4279-4F56-9D4D-8EFD53A4604DQ37444081-854B4FB7-EFA7-4582-B554-C6EF50002802Q37638896-B4381D42-1814-4E42-A03E-F89AB4C7D7E5Q37721526-EBF59235-D40D-4041-A72D-6FB3DF89A227Q38078108-2BD9A5CB-B24A-4474-A21A-AB13C31A128BQ38134094-D152153B-9B35-4FD2-B5CB-71207D64F513Q38610301-FA9E918E-D3AD-4A79-BE8B-317B099CC512Q38766127-BEC3DFED-4002-43BD-8997-53DDF4716891Q38775871-4246E83A-A0A1-4718-AF5B-7C4AB689BA41Q38945159-64DE2503-8DCE-43FD-A683-DBE3A3C71133Q38957570-B4D13252-4FE1-4BDA-BE1C-043144AA2AE9Q39065889-D82F8D97-C951-4E47-B9AE-CFC0ED569DB7Q41706913-62A34855-B249-4E04-892C-7A210489CDECQ41827184-44ED1FC0-E891-46A9-B1E6-724765B513E5Q42319016-18B69954-EB1E-40D6-BEBE-982A8E4ECC5EQ42648185-5F47F21F-6FF8-435C-8BEB-80837AD8424AQ43438669-57F7EC5B-D9BB-48BC-AD0B-1A5B562E4842Q43491287-B133E2D1-A423-4EE7-B390-C17C55FBE9F1Q43753631-F6179324-5E7B-49FE-9F4C-F210AF019D83Q43919851-9D46E43B-6AEA-4AB0-8E5E-01982EB84192
P2860
Reproducibility of 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET tumor volume measurements.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Reproducibility of 18F-FDG and ...... PET tumor volume measurements.
@en
Reproducibility of 18F-FDG and ...... PET tumor volume measurements.
@nl
type
label
Reproducibility of 18F-FDG and ...... PET tumor volume measurements.
@en
Reproducibility of 18F-FDG and ...... PET tumor volume measurements.
@nl
prefLabel
Reproducibility of 18F-FDG and ...... PET tumor volume measurements.
@en
Reproducibility of 18F-FDG and ...... PET tumor volume measurements.
@nl
P2093
P1476
Reproducibility of 18F-FDG and ...... PET tumor volume measurements.
@en
P2093
Catherine Cheze-Le Rest
Dimitris Visvikis
Eric O Aboagye
Jean-Philippe Metges
Laura M Kenny
Lula Rosso
Mathieu Hatt
Nidal M Albarghach
Olivier Pradier
P304
P356
10.2967/JNUMED.110.078501
P407
P577
2010-08-18T00:00:00Z